EIVAX
Price
$14.61
Change
+$0.07 (+0.48%)
Updated
Jul 3 closing price
Net Assets
1.8B
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

EIVAX vs VIVAX

Header iconEIVAX vs VIVAX Comparison
Open Charts EIVAX vs VIVAXBanner chart's image
Allspring Special Large Cap Value A
Price$14.61
Change+$0.07 (+0.48%)
VolumeN/A
Net Assets1.8B
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
EIVAX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
EIVAX vs. VIVAX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EIVAX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. EIVAX (1.8B). VIVAX pays higher dividends than EIVAX: VIVAX (2.06) vs EIVAX (0.63). EIVAX was incepted earlier than VIVAX: EIVAX (19 years) vs VIVAX (33 years). EIVAX (0.88) is less costly to investors than VIVAX (0.17). EIVAX is a more actively managed with annual turnover of: 36.00 vs. VIVAX (9.00). EIVAX has a lower initial minimum investment than VIVAX: EIVAX (1000) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 12.04 vs. EIVAX (7.99). VIVAX return over 5 years is better than : 80.14 vs. EIVAX (36.07).
EIVAXVIVAXEIVAX / VIVAX
Total Expense Ratio0.820.17482%
Annual Report Gross Expense Ratio0.880.17518%
Fund Existence19 years33 years-
Gain YTD10.5146.209169%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.8B189B1%
Annual Yield % from dividends0.632.0631%
Returns for 1 year7.9912.0466%
Returns for 3 years35.2935.16100%
Returns for 5 years36.0780.1445%
Returns for 10 years13.31115.7411%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOL1.910.03
+1.60%
Emeren Group Ltd
CE60.880.26
+0.43%
Celanese Corp
BNL16.340.03
+0.18%
Broadstone Net Lease
BCLI1.16-0.01
-0.85%
Brainstorm Cell Therapeutics
ECX2.16-0.04
-1.82%
ECARX Holdings